메뉴 건너뛰기
British Journal of Pharmacology
Volumn 167, Issue 7, 2012, Pages 1395-1397
Why is publication of negative clinical trial data important?
Author keywords

Clinical trial; negative data
Indexed keywords

1 (2 BROMOPHENYL) 3 [1 (5 TRIFLUOROMETHYL 2 PYRIDINYL) 3 PYRROLIDINYL]UREA; AZD 1386; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1 ANTAGONIST;
EID: 84868632227     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2012.02215.x     Document Type: Review
Times cited : (14)
References (9)
  • 1
    • 79551575056 scopus 로고    scopus 로고
    • Phase III and submission failures 2007-2010
    • Arrowsmith J, (2011a). Phase III and submission failures 2007-2010. Nat Rev Drug Discov 10: 87.
    • (2011) Nat Rev Drug Discov , vol.10 , pp. 87
    • Arrowsmith, J.1
  • 2
    • 79955601786 scopus 로고    scopus 로고
    • Phase II failures 2008-2010
    • Arrowsmith J, (2011b). Phase II failures 2008-2010. Nat Rev Drug Discov 10: 328-329.
    • (2011) Nat Rev Drug Discov , vol.10 , pp. 328-329
    • Arrowsmith, J.1
  • 3
    • 34848820269 scopus 로고    scopus 로고
    • The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans
    • Chizh BA, O'Donnell MB, Napolitano A, Wang J, Brooke AC, Aylott MC, et al,. (2007). The effects of the TRPV1 antagonist SB-705498 on TRPV1 receptor-mediated activity and inflammatory hyperalgesia in humans. Pain 132: 132-141.
    • (2007) Pain , vol.132 , pp. 132-141
    • Chizh, B.A.1    O'Donnell, M.B.2    Napolitano, A.3    Wang, J.4    Brooke, A.C.5    Aylott, M.C.6
  • 4
    • 79956089875 scopus 로고    scopus 로고
    • Precompetitive collaborations in the pharmaceutical industry
    • Elkins S.E. Hupcey M.A. Williams A.J. (eds). John Wiley and Sons: Hoboken, NJ
    • Hunter AJ, (2011). Precompetitive collaborations in the pharmaceutical industry. In:, Elkins SE, Hupcey MA, Williams AJ, (eds). Collaborative Computational Technologies for Biomedical Research. John Wiley and Sons: Hoboken, NJ, pp. 55-84.
    • (2011) Collaborative Computational Technologies for Biomedical Research , pp. 55-84
    • Hunter, A.J.1
  • 5
    • 34347403252 scopus 로고    scopus 로고
    • Drug development for CNS disorders: Strategies for balancing risk and reducing attrition
    • Pangalos M, Schechter L, Hurko O, (2007). Drug development for CNS disorders: strategies for balancing risk and reducing attrition. Nat Rev Drug Discov 6: 521-532.
    • (2007) Nat Rev Drug Discov , vol.6 , pp. 521-532
    • Pangalos, M.1    Schechter, L.2    Hurko, O.3
  • 7
    • 80055088241 scopus 로고    scopus 로고
    • Believe it or not: How much can we rely on published data on potential drug targets?
    • Prinz P, Schlange T, Asadullah K, (2011). Believe it or not: how much can we rely on published data on potential drug targets? Nat Rev Drug Discov 10: 712-713.
    • (2011) Nat Rev Drug Discov , vol.10 , pp. 712-713
    • Prinz, P.1    Schlange, T.2    Asadullah, K.3
  • 8
    • 34248138496 scopus 로고    scopus 로고
    • The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
    • Szallasi A, Cortright DN, Blum CA, Eid SR, (2007). The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 6: 357-372.
    • (2007) Nat Rev Drug Discov , vol.6 , pp. 357-372
    • Szallasi, A.1    Cortright, D.N.2    Blum, C.A.3    Eid, S.R.4
  • 9
    • 29544449337 scopus 로고    scopus 로고
    • Trial Registration at ClinicalTrials.gov between May and October 2005
    • Zarin D, Tse T, Ide NC, (2005). Trial Registration at ClinicalTrials.gov between May and October 2005. N Engl J Med 353: 2779-2787.
    • (2005) N Engl J Med , vol.353 , pp. 2779-2787
    • Zarin, D.1    Tse, T.2    Ide, N.C.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.